Investors

SEC Filings

SEC Filings

Filing date	Form	Description	View
November 10, 2020	SC 13G	A statement of beneficial ownership of common stock by certain persons	0000902219-20-000435.pdf 0000902219-20-000435.rtf 0000902219-20-000435.xls View HTML
February 10, 2021	SC 13G	A statement of beneficial ownership of common stock by certain persons	0001104659-21-017368.pdf 0001104659-21-017368.rtf View HTML
February 11, 2021	SC 13G	A statement of beneficial ownership of common stock by certain persons	0000093751-21-000286.pdf 0000093751-21-000286.rtf View HTML
July 8, 2022	SC 13G	A statement of beneficial ownership of common stock by certain persons	0000834237-22-010253.pdf 0000834237-22-010253.rtf View HTML
December 19, 2022	SC 13G	A statement of beneficial ownership of common stock by certain persons	0000895345-22-000827.pdf 0000895345-22-000827.rtf View HTML
April 10, 2020	PRE 14A	A preliminary proxy statement providing notification matters to be brought to a vote	0001193125-20-103794.pdf 0001193125-20-103794.rtf 0001193125-20-103794.xls View HTML
February 17, 2023	PRE 14A	A preliminary proxy statement providing notification matters to be brought to a vote	0001193125-23-042106.pdf 0001193125-23-042106.rtf 0001193125-23-042106.xls View HTML
April 8, 2011	D		0001517022-11-000001.pdf 0001517022-11-000001.rtf 0001517022-11-000001.xls View HTML
April 21, 2011	D/A		0001517022-11-000002.pdf 0001517022-11-000002.rtf 0001517022-11-000002.xls View HTML

Data provided by Kaleidoscope.

Print Page

Email Page

Contact IR

Email Alerts

Tear Sheet

Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142

Driving Directions

+1 617.871.2098 phone
+1 617.871.2099 fax